<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9995">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02005705</url>
  </required_header>
  <id_info>
    <org_study_id>HIC 1307012373</org_study_id>
    <nct_id>NCT02005705</nct_id>
  </id_info>
  <brief_title>Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.</brief_title>
  <official_title>Randomized Trial of Outpatient vs. Inpatient Management of Low-risk Patients With Upper Gastrointestinal Bleeding.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients presenting to the emergency room with upper gastrointestinal bleeding and a Glasgow
      Blatchford score of zero will be randomly assigned to further care in the inpatient vs.
      outpatient setting. The hypothesis of this study is that patients who are managed as
      outpatients will require interventions at a rate not higher than those managed as inpatients
      and will have lower direct healthcare costs.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The number of patients requiring intervention for UGIB (endoscopic therapy, blood transfusion, surgery, interventional radiology)</measure>
    <time_frame>Within 7 days of the index presentation to the emergency room</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">242</enrollment>
  <condition>Upper Gastrointestinal Bleeding</condition>
  <arm_group>
    <arm_group_label>Outpatient</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Inpatient</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Outpatient Management of Low-risk Patients</intervention_name>
    <description>Labs will be obtained within 2-3 days of discharge from ED
Clinic visit will be scheduled within 3 days of discharge from ED
EGD will be scheduled within 7 days of discharge from ED
Phone follow-up at day 7 and 30</description>
    <arm_group_label>Outpatient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inpatient Management of Low-risk Patients</intervention_name>
    <description>Labs will be obtained on day of discharge or day 2-3
EGD will be performed in the hospital
Phone follow-up at day 7 and 30</description>
    <arm_group_label>Inpatient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Blood Urea Nitrogen &lt; 18.2 mg/dl

          2. Hemoglobin ≥ 13.0 g/dl for men and ≥ 12.0 g/dl for women

          3. Systolic blood pressure ≥ 110 mm Hg

          4. Heart rate &lt; 100 beats/min

        Exclusion Criteria:

          1. Inability to obtain informed consent

          2. Pregnancy

          3. History of liver disease

          4. History of heart failure

          5. Syncope that is temporally related to ongoing bleeding

          6. Melena

          7. Contraindication to proton pump inhibitor use

          8. Other conditions that necessitate inpatient evaluation.

          9. Inpatients with new onset of GI bleeding
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Loren Laine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University, Section of Digestive Disease</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Loren Laine, MD</last_name>
    <phone>203-937-3462</phone>
    <email>loren.laine@yale.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 6, 2013</lastchanged_date>
  <firstreceived_date>December 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yale University</investigator_affiliation>
    <investigator_full_name>Loren Laine</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
